← back to search

Changdong Guan

Heilongjiang University of Chinese Medicine · CN
Area of research
Surgery · Radiology, Nuclear Medicine and Imaging
Research interest
Research interests include Coronary Interventions and Diagnostics, Cardiac Imaging and Diagnostics, Acute Myocardial Infarction Research, and Peripheral Artery Disease Management.
h-index
26
citations
2,704
works
159
NIH funding
primary concept
email

Recent publications

Angiographic Quantitative Flow Ratio–Guided Treatment of Patients With Physiologically Intermediate Coronary Lesions
Journal of the American Heart Association 2025cited by 3position: middledoi
Rationales Behind Physiology-Guided Revascularization
JACC: Cardiovascular Interventions 2025cited by 2position: middledoi
Prognostic impact of guideline-directed medical therapy after functionally complete revascularisation in patients with obstructive coronary artery diseases
Heart 2025cited by 1position: middledoi
Short-Term Risk Stratification of Non–Flow-Limiting Coronary Stenosis by Angiographically Derived Radial Wall Strain
Journal of the American College of Cardiology 2023cited by 25position: middledoi
Sex Differences in Clinical Outcomes Associated With Quantitative Flow Ratio-Guided Percutaneous Coronary Intervention
JACC Asia 2023cited by 4position: middledoi
Cost-Effectiveness of Angiographic Quantitative Flow Ratio-Guided Coronary Intervention: A Multicentre, Randomised, Sham-Controlled Trial
SSRN Electronic Journal 2023cited by 1position: middledoi
2-Year Outcomes of Angiographic Quantitative Flow Ratio-Guided Coronary Interventions
Journal of the American College of Cardiology 2022cited by 96position: middledoi
Prognostic Implications of Prestent Pullback Pressure Gradient and Poststent Quantitative Flow Ratio in Patients Undergoing Percutaneous Coronary Intervention
Journal of the American Heart Association 2022cited by 30position: middledoi
Coronary Intervention Guided by Quantitative Flow Ratio vs Angiography in Patients With or Without Diabetes
Journal of the American College of Cardiology 2022cited by 13position: middledoi
Active SB-P Versus Conventional Approach to the Protection of High-Risk Side Branches
JACC: Cardiovascular Interventions 2020cited by 26position: middledoi
Comparison between two biodegradable polymer-based sirolimus-eluting stents with differing drug elution and polymer absorption kinetics: two-year clinical outcomes of the PANDA III trial
EuroIntervention 2018cited by 9position: middledoi
Diagnostic Accuracy of Angiography-Based Quantitative Flow Ratio Measurements for Online Assessment of Coronary Stenosis
Journal of the American College of Cardiology 2017cited by 534position: middledoi
Biodegradable Polymer-Based Sirolimus-Eluting Stents With Differing Elution and Absorption Kinetics
Journal of the American College of Cardiology 2016cited by 49position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Shubin Qiao · Hebei Medical University8 papers (2017–2025)Bo Xu · Jiangnan University8 papers (2016–2025)Shengxian Tu · Shanghai Jiao Tong University6 papers (2017–2025)Guosheng Fu · The First Affiliated Hospital, Sun Yat-sen University6 papers (2022–2025)Zening Jin · Capital University6 papers (2022–2025)Xinkai Qu · Fudan University5 papers (2022–2025)Yanyan Zhao · Nanjing Agricultural University5 papers (2020–2025)Lei Song · The First Affiliated Hospital, Sun Yat-sen University5 papers (2022–2025)Bo Yu · Tongji University4 papers (2022–2025)Yundai Chen · Nankai University4 papers (2017–2023)William Wijns · Ollscoil na Gaillimhe – University of Galway3 papers (2017–2025)Gregg W. Stone · Icahn School of Medicine at Mount Sinai3 papers (2016–2025) · 3 papers (2020–2023)Jianan Wang · University of Alabama at Birmingham3 papers (2016–2025) · 2 papers (2023–2025)Lilei Yu · University of Manitoba2 papers (2023–2025)Feng Tian · Shanghai University2 papers (2017–2023)Yuejin Yang · Tianjin University of Traditional Chinese Medicine2 papers (2016–2020)Bo Yu · Ningxia Medical University2 papers (2023–2023)Xuebin Cao · Ningbo University2 papers (2016–2018)